

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.68798331 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.68798331 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.40741975 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.40741975 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.15811961 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.09681952 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.65957692 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.65957692 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.65957692 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.59730083 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.41906283 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.35457764 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.34586734 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.34586734 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.33416009 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.31970144 |
| 17 | urea cycle (GO:0000050) | 5.29779378 |
| 18 | urea metabolic process (GO:0019627) | 5.29779378 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.25213087 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.21576250 |
| 21 | protein carboxylation (GO:0018214) | 5.12196059 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.12196059 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.09263099 |
| 24 | glyoxylate metabolic process (GO:0046487) | 5.06410384 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.02155505 |
| 26 | cysteine metabolic process (GO:0006534) | 4.99463116 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.98103727 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.96433557 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.93360271 |
| 30 | regulation of fibrinolysis (GO:0051917) | 4.92328362 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.85701121 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84653830 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.84520294 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.64963651 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.64807891 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.63922620 |
| 37 | bile acid metabolic process (GO:0008206) | 4.62957441 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.60541762 |
| 39 | phospholipid efflux (GO:0033700) | 4.58695942 |
| 40 | regulation of complement activation (GO:0030449) | 4.54573330 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.52773927 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 4.51291333 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 4.51291333 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.51291333 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.51291333 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.51291333 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 4.51291333 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.50639596 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.50639596 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.48987160 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.48987160 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.48987160 |
| 53 | aromatic amino acid family metabolic process (GO:0009072) | 4.42579440 |
| 54 | homocysteine metabolic process (GO:0050667) | 4.40097113 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 4.31953077 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.31837625 |
| 57 | lysine metabolic process (GO:0006553) | 4.29770981 |
| 58 | lysine catabolic process (GO:0006554) | 4.29770981 |
| 59 | tyrosine metabolic process (GO:0006570) | 4.28608318 |
| 60 | detection of other organism (GO:0098543) | 4.27515337 |
| 61 | acylglycerol homeostasis (GO:0055090) | 4.22469137 |
| 62 | triglyceride homeostasis (GO:0070328) | 4.22469137 |
| 63 | detection of bacterium (GO:0016045) | 4.21460159 |
| 64 | cholesterol efflux (GO:0033344) | 4.13475525 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.11820411 |
| 66 | plasma lipoprotein particle assembly (GO:0034377) | 4.09650246 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 4.07710694 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 3.97863353 |
| 69 | leukocyte aggregation (GO:0070486) | 3.95499037 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 3.95482997 |
| 71 | cellular glucuronidation (GO:0052695) | 3.88613365 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 3.85444157 |
| 73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.84127318 |
| 74 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.84127318 |
| 75 | amine catabolic process (GO:0009310) | 3.83222016 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 3.83222016 |
| 77 | phospholipid homeostasis (GO:0055091) | 3.82679354 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 3.80675037 |
| 79 | glycine metabolic process (GO:0006544) | 3.80250856 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 3.78871358 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.78788025 |
| 82 | ethanol oxidation (GO:0006069) | 3.77927586 |
| 83 | protein-lipid complex assembly (GO:0065005) | 3.77172984 |
| 84 | fibrinolysis (GO:0042730) | 3.76050220 |
| 85 | glutamate metabolic process (GO:0006536) | 3.75497684 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74633545 |
| 87 | cellular amino acid catabolic process (GO:0009063) | 3.73974405 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 3.72978836 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 3.71501539 |
| 90 | low-density lipoprotein particle remodeling (GO:0034374) | 3.71256226 |
| 91 | detection of external biotic stimulus (GO:0098581) | 3.69786347 |
| 92 | drug catabolic process (GO:0042737) | 3.66836869 |
| 93 | response to interleukin-15 (GO:0070672) | 3.66227892 |
| 94 | coenzyme catabolic process (GO:0009109) | 3.65442623 |
| 95 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64816420 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.64633990 |
| 97 | serine family amino acid metabolic process (GO:0009069) | 3.63037727 |
| 98 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.62716233 |
| 99 | response to peptidoglycan (GO:0032494) | 3.61632716 |
| 100 | cholesterol homeostasis (GO:0042632) | 3.60577967 |
| 101 | plasma lipoprotein particle organization (GO:0071827) | 3.60251245 |
| 102 | arginine metabolic process (GO:0006525) | 3.55419820 |
| 103 | sterol homeostasis (GO:0055092) | 3.55242951 |
| 104 | complement activation, classical pathway (GO:0006958) | 3.54960377 |
| 105 | complement activation (GO:0006956) | 3.54157297 |
| 106 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.52889041 |
| 107 | protein activation cascade (GO:0072376) | 3.50014098 |
| 108 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.49997324 |
| 109 | cofactor catabolic process (GO:0051187) | 3.47469337 |
| 110 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.47434516 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.46989042 |
| 112 | aldehyde catabolic process (GO:0046185) | 3.46833363 |
| 113 | blood coagulation, intrinsic pathway (GO:0007597) | 3.46654899 |
| 114 | intestinal cholesterol absorption (GO:0030299) | 3.44621289 |
| 115 | uronic acid metabolic process (GO:0006063) | 3.44595771 |
| 116 | glucuronate metabolic process (GO:0019585) | 3.44595771 |
| 117 | protein-lipid complex subunit organization (GO:0071825) | 3.44580512 |
| 118 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43472206 |
| 119 | detection of molecule of bacterial origin (GO:0032490) | 3.43434866 |
| 120 | ketone body metabolic process (GO:1902224) | 3.43277593 |
| 121 | flavonoid metabolic process (GO:0009812) | 3.42215363 |
| 122 | neutrophil activation involved in immune response (GO:0002283) | 3.41011410 |
| 123 | acute-phase response (GO:0006953) | 3.40046812 |
| 124 | cellular extravasation (GO:0045123) | 3.39720256 |
| 125 | lipoprotein metabolic process (GO:0042157) | 3.39418975 |
| 126 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.38842194 |
| 127 | negative regulation of interleukin-12 production (GO:0032695) | 3.37544845 |
| 128 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37342969 |
| 129 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35920282 |
| 130 | tolerance induction (GO:0002507) | 3.35772969 |
| 131 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.34706818 |
| 132 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.34706818 |
| 133 | serine family amino acid biosynthetic process (GO:0009070) | 3.34561256 |
| 134 | detection of biotic stimulus (GO:0009595) | 3.30487347 |
| 135 | response to type I interferon (GO:0034340) | 3.30053781 |
| 136 | cellular response to type I interferon (GO:0071357) | 3.28479124 |
| 137 | type I interferon signaling pathway (GO:0060337) | 3.28479124 |
| 138 | regulation of T cell tolerance induction (GO:0002664) | 3.28294965 |
| 139 | positive thymic T cell selection (GO:0045059) | 3.28161231 |
| 140 | negative thymic T cell selection (GO:0045060) | 3.26373817 |
| 141 | thymic T cell selection (GO:0045061) | 3.25225438 |
| 142 | cellular response to interleukin-15 (GO:0071350) | 3.18026944 |
| 143 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.16329783 |
| 144 | negative T cell selection (GO:0043383) | 3.13767302 |
| 145 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.04640769 |
| 146 | response to host immune response (GO:0052572) | 3.04640769 |
| 147 | T cell selection (GO:0045058) | 3.03540918 |
| 148 | germinal center formation (GO:0002467) | 3.01686672 |
| 149 | NIK/NF-kappaB signaling (GO:0038061) | 3.00757256 |
| 150 | response to host (GO:0075136) | 3.00508653 |
| 151 | response to host defenses (GO:0052200) | 3.00508653 |
| 152 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00508653 |
| 153 | response to muramyl dipeptide (GO:0032495) | 2.98686187 |
| 154 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.96307764 |
| 155 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92147323 |
| 156 | regulation of tolerance induction (GO:0002643) | 2.91803647 |
| 157 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90816904 |
| 158 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.89019917 |
| 159 | immunoglobulin mediated immune response (GO:0016064) | 2.88156316 |
| 160 | negative regulation of T cell mediated immunity (GO:0002710) | 2.84004698 |
| 161 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83835443 |
| 162 | respiratory burst (GO:0045730) | 2.83058910 |
| 163 | response to laminar fluid shear stress (GO:0034616) | 2.81488610 |
| 164 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80759943 |
| 165 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79974139 |
| 166 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78939609 |
| 167 | negative regulation of phagocytosis (GO:0050765) | 2.77565443 |
| 168 | negative regulation of innate immune response (GO:0045824) | 2.73888931 |
| 169 | positive T cell selection (GO:0043368) | 2.73787113 |
| 170 | mannose metabolic process (GO:0006013) | 2.72762981 |
| 171 | B cell receptor signaling pathway (GO:0050853) | 2.71686415 |
| 172 | regulation of mast cell degranulation (GO:0043304) | 2.70357609 |
| 173 | neutrophil activation (GO:0042119) | 2.70263772 |
| 174 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.69725522 |
| 175 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.69240148 |
| 176 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.68683824 |
| 177 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.68374275 |
| 178 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.67851025 |
| 179 | myeloid cell activation involved in immune response (GO:0002275) | 2.66877508 |
| 180 | defense response to protozoan (GO:0042832) | 2.65016979 |
| 181 | regulation of leukocyte degranulation (GO:0043300) | 2.62114192 |
| 182 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.61736878 |
| 183 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.61736878 |
| 184 | positive regulation of tolerance induction (GO:0002645) | 2.60662069 |
| 185 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.58327764 |
| 186 | myeloid dendritic cell differentiation (GO:0043011) | 2.58182087 |
| 187 | macrophage activation (GO:0042116) | 2.57627932 |
| 188 | T cell migration (GO:0072678) | 2.57254498 |
| 189 | granulocyte activation (GO:0036230) | 2.56739767 |
| 190 | negative regulation of type 2 immune response (GO:0002829) | 2.56081752 |
| 191 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55290978 |
| 192 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.55074913 |
| 193 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.55074913 |
| 194 | negative regulation of interleukin-6 production (GO:0032715) | 2.53093902 |
| 195 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.52782359 |
| 196 | regulation of B cell differentiation (GO:0045577) | 2.52365888 |
| 197 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.50671968 |
| 198 | protein localization to endosome (GO:0036010) | 2.47112131 |
| 199 | regulation of extracellular matrix disassembly (GO:0010715) | 2.46798452 |
| 200 | response to protozoan (GO:0001562) | 2.46539320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.31090936 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.40930795 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.83930590 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.72306021 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.45436101 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.28908760 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.28242310 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.43898692 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.29206800 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.85016784 |
| 11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.64051086 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.26715449 |
| 13 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.23381582 |
| 14 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.22428835 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.20273003 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08441555 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03452407 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00175539 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1867915 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90349825 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85026416 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.78393462 |
| 23 | * MAF_26560356_Chip-Seq_TH2_Human | 1.77293381 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.76010322 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73014044 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71358266 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69534404 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63193322 |
| 29 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.58552448 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56970065 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54805994 |
| 32 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50516084 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50358227 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48584726 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48224813 |
| 36 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47707546 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47544883 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47359136 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47272446 |
| 40 | * MYB_26560356_Chip-Seq_TH2_Human | 1.46553229 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46348668 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43919633 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35672082 |
| 44 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34559448 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31930151 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30485123 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29244329 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27248384 |
| 49 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25838319 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24869986 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24065537 |
| 52 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23484498 |
| 53 | P68_20966046_ChIP-Seq_HELA_Human | 1.22798872 |
| 54 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22521276 |
| 55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21522006 |
| 56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20465086 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16601693 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16163571 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15640637 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15620919 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11361333 |
| 62 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10571428 |
| 63 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09673849 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09115170 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07252572 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07215840 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06833082 |
| 68 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06739657 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05806863 |
| 70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05406152 |
| 71 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04952464 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01931162 |
| 73 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01475592 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01392820 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00467025 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00137124 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99680642 |
| 78 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99386955 |
| 79 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99294537 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97366329 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97162544 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96964197 |
| 83 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96140172 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92849741 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92576225 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91718040 |
| 87 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91639161 |
| 88 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.90861879 |
| 89 | * MAF_26560356_Chip-Seq_TH1_Human | 0.88477398 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88027603 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86265235 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85724017 |
| 93 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82067568 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.79866130 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79062320 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78300339 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78115536 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77696654 |
| 99 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.77232167 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76331569 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75535733 |
| 102 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75116081 |
| 103 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74698753 |
| 104 | MYC_22102868_ChIP-Seq_BL_Human | 0.74504527 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.73349745 |
| 106 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.73087944 |
| 107 | * MYB_26560356_Chip-Seq_TH1_Human | 0.72391018 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.71611710 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71114934 |
| 110 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.70732233 |
| 111 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70566284 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70072720 |
| 113 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69965279 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69819223 |
| 115 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69254746 |
| 116 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.69181227 |
| 117 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.69147513 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.69049121 |
| 119 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.68683861 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68125382 |
| 121 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.65764326 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.65222698 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.65200561 |
| 124 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.65153952 |
| 125 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65043530 |
| 126 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64273493 |
| 127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.63235600 |
| 128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.63232535 |
| 129 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62673382 |
| 130 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.62668559 |
| 131 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.62273770 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61918165 |
| 133 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.61647551 |
| 134 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.61393647 |
| 135 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.61334469 |
| 136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.61306689 |
| 137 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.61258225 |
| 138 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.61132108 |
| 139 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60772601 |
| 140 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.59334069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.41080665 |
| 2 | MP0005360_urolithiasis | 6.66409633 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.53475763 |
| 4 | MP0005365_abnormal_bile_salt | 5.40608284 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.55241321 |
| 6 | MP0003252_abnormal_bile_duct | 3.60025731 |
| 7 | MP0009840_abnormal_foam_cell | 3.45649979 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.27036388 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.24285370 |
| 10 | MP0005083_abnormal_biliary_tract | 3.00103737 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.66639924 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.54931749 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.48973152 |
| 14 | MP0005332_abnormal_amino_acid | 2.35900265 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.33252293 |
| 16 | MP0000609_abnormal_liver_physiology | 2.17255537 |
| 17 | MP0003195_calcinosis | 2.15122475 |
| 18 | MP0008260_abnormal_autophagy | 2.09604248 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.90060013 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.85876847 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.82728539 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.78611213 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.76630106 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.75269734 |
| 25 | MP0002405_respiratory_system_inflammati | 1.74770010 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.74639916 |
| 27 | MP0002132_abnormal_respiratory_system | 1.66362369 |
| 28 | MP0003868_abnormal_feces_composition | 1.63808236 |
| 29 | MP0000858_altered_metastatic_potential | 1.62570359 |
| 30 | MP0000716_abnormal_immune_system | 1.59510691 |
| 31 | MP0002398_abnormal_bone_marrow | 1.57509187 |
| 32 | MP0009278_abnormal_bone_marrow | 1.52394518 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49536079 |
| 34 | MP0003828_pulmonary_edema | 1.46938078 |
| 35 | MP0002998_abnormal_bone_remodeling | 1.46446754 |
| 36 | MP0003866_abnormal_defecation | 1.45450181 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.44971672 |
| 38 | MP0004381_abnormal_hair_follicle | 1.43914275 |
| 39 | MP0003436_decreased_susceptibility_to | 1.43579526 |
| 40 | MP0004858_abnormal_nervous_system | 1.40275854 |
| 41 | MP0001764_abnormal_homeostasis | 1.39956646 |
| 42 | MP0002933_joint_inflammation | 1.32811837 |
| 43 | MP0009764_decreased_sensitivity_to | 1.30702580 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.30439921 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.30106477 |
| 46 | MP0005451_abnormal_body_composition | 1.29606339 |
| 47 | MP0002722_abnormal_immune_system | 1.28573480 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.27972001 |
| 49 | MP0000598_abnormal_liver_morphology | 1.27123121 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.26868482 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.26672933 |
| 52 | MP0002429_abnormal_blood_cell | 1.26191980 |
| 53 | MP0001849_ear_inflammation | 1.24376456 |
| 54 | MP0000604_amyloidosis | 1.23323659 |
| 55 | MP0008469_abnormal_protein_level | 1.23054006 |
| 56 | MP0001851_eye_inflammation | 1.21143512 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.20372780 |
| 58 | MP0003279_aneurysm | 1.20219196 |
| 59 | MP0005310_abnormal_salivary_gland | 1.20199794 |
| 60 | MP0002254_reproductive_system_inflammat | 1.18174577 |
| 61 | MP0003186_abnormal_redox_activity | 1.16950981 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.16559872 |
| 63 | MP0009763_increased_sensitivity_to | 1.15328743 |
| 64 | MP0003091_abnormal_cell_migration | 1.15207696 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.15186546 |
| 66 | MP0003300_gastrointestinal_ulcer | 1.12506570 |
| 67 | MP0003303_peritoneal_inflammation | 1.11138226 |
| 68 | MP0008004_abnormal_stomach_pH | 1.10898535 |
| 69 | MP0003045_fibrosis | 1.10204254 |
| 70 | MP0000685_abnormal_immune_system | 1.10183758 |
| 71 | MP0005164_abnormal_response_to | 1.10028121 |
| 72 | MP0003011_delayed_dark_adaptation | 1.05537513 |
| 73 | MP0009697_abnormal_copulation | 1.04583764 |
| 74 | MP0006082_CNS_inflammation | 1.00352580 |
| 75 | MP0001663_abnormal_digestive_system | 1.00079513 |
| 76 | MP0005390_skeleton_phenotype | 0.99796704 |
| 77 | MP0000767_abnormal_smooth_muscle | 0.98905340 |
| 78 | MP0000490_abnormal_crypts_of | 0.93040222 |
| 79 | MP0009785_altered_susceptibility_to | 0.92059473 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.91827295 |
| 81 | MP0003724_increased_susceptibility_to | 0.90421500 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.90350531 |
| 83 | MP0002419_abnormal_innate_immunity | 0.90218991 |
| 84 | MP0005025_abnormal_response_to | 0.89552730 |
| 85 | MP0005647_abnormal_sex_gland | 0.89090008 |
| 86 | MP0001853_heart_inflammation | 0.88717996 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.88633489 |
| 88 | MP0001790_abnormal_immune_system | 0.88448499 |
| 89 | MP0005387_immune_system_phenotype | 0.88448499 |
| 90 | MP0003448_altered_tumor_morphology | 0.86430659 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.85458389 |
| 92 | MP0001845_abnormal_inflammatory_respons | 0.85289233 |
| 93 | MP0001800_abnormal_humoral_immune | 0.84864901 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.83731269 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 0.83731269 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.81918234 |
| 97 | MP0001958_emphysema | 0.80615229 |
| 98 | MP0010368_abnormal_lymphatic_system | 0.80415912 |
| 99 | MP0004947_skin_inflammation | 0.79958472 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 0.78867065 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.73953159 |
| 102 | MP0005408_hypopigmentation | 0.72462534 |
| 103 | MP0005334_abnormal_fat_pad | 0.72211872 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.71356774 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 0.71237709 |
| 106 | MP0004130_abnormal_muscle_cell | 0.70753098 |
| 107 | MP0003075_altered_response_to | 0.70582784 |
| 108 | MP0002928_abnormal_bile_duct | 0.69703275 |
| 109 | MP0003795_abnormal_bone_structure | 0.69339629 |
| 110 | MP0001915_intracranial_hemorrhage | 0.68908372 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.68684177 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.68412039 |
| 113 | MP0000343_altered_response_to | 0.68382959 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.67355315 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.67045150 |
| 116 | MP0003690_abnormal_glial_cell | 0.66844731 |
| 117 | MP0005166_decreased_susceptibility_to | 0.66685740 |
| 118 | MP0002971_abnormal_brown_adipose | 0.66462681 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.66375187 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.65999944 |
| 121 | MP0001756_abnormal_urination | 0.65905808 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.65200302 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.64502650 |
| 124 | MP0002723_abnormal_immune_serum | 0.64017489 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.63602474 |
| 126 | MP0005670_abnormal_white_adipose | 0.63472773 |
| 127 | MP0005000_abnormal_immune_tolerance | 0.62711018 |
| 128 | MP0008873_increased_physiological_sensi | 0.57067450 |
| 129 | MP0000249_abnormal_blood_vessel | 0.56556120 |
| 130 | MP0005535_abnormal_body_temperature | 0.54670839 |
| 131 | MP0006036_abnormal_mitochondrial_physio | 0.54527189 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.53111041 |
| 133 | MP0002876_abnormal_thyroid_physiology | 0.52233754 |
| 134 | MP0004510_myositis | 0.50693142 |
| 135 | MP0005671_abnormal_response_to | 0.50470609 |
| 136 | MP0005448_abnormal_energy_balance | 0.49951646 |
| 137 | MP0000689_abnormal_spleen_morphology | 0.49559145 |
| 138 | MP0001661_extended_life_span | 0.49517290 |
| 139 | MP0003329_amyloid_beta_deposits | 0.48721693 |
| 140 | MP0001873_stomach_inflammation | 0.47776588 |
| 141 | MP0008874_decreased_physiological_sensi | 0.47691223 |
| 142 | MP0004883_abnormal_blood_vessel | 0.45607311 |
| 143 | MP0001819_abnormal_immune_cell | 0.45305697 |
| 144 | MP0001243_abnormal_dermal_layer | 0.45305096 |
| 145 | MP0003453_abnormal_keratinocyte_physiol | 0.45252906 |
| 146 | MP0009115_abnormal_fat_cell | 0.45098570 |
| 147 | MP0002420_abnormal_adaptive_immunity | 0.44695142 |
| 148 | MP0005023_abnormal_wound_healing | 0.44147335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.90679564 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.45901024 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.28062642 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.95598820 |
| 5 | Xanthomatosis (HP:0000991) | 5.81264708 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.68408021 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.63381664 |
| 8 | Eczematoid dermatitis (HP:0000976) | 5.60366697 |
| 9 | Complement deficiency (HP:0004431) | 5.02736360 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.01541772 |
| 11 | Joint hemorrhage (HP:0005261) | 4.62684011 |
| 12 | Myositis (HP:0100614) | 4.53211296 |
| 13 | Orchitis (HP:0100796) | 4.32481450 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.23636979 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.23539756 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.23122837 |
| 17 | Recurrent abscess formation (HP:0002722) | 4.16054478 |
| 18 | Epidermoid cyst (HP:0200040) | 4.04039864 |
| 19 | Hyperammonemia (HP:0001987) | 4.00144294 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.99854341 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.97072192 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.91818955 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.88037298 |
| 24 | Optic neuritis (HP:0100653) | 3.88037298 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.85482924 |
| 26 | Abnormality of complement system (HP:0005339) | 3.84594350 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.74141346 |
| 28 | Fat malabsorption (HP:0002630) | 3.71306079 |
| 29 | Ketosis (HP:0001946) | 3.68968252 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.57181301 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 3.54757568 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.52903933 |
| 33 | Myocardial infarction (HP:0001658) | 3.50607960 |
| 34 | Hyperglycinemia (HP:0002154) | 3.47834735 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43712017 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.41131291 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 3.40307299 |
| 38 | Stomatitis (HP:0010280) | 3.39696448 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 3.37612805 |
| 40 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.36059691 |
| 41 | Hypoglycemic coma (HP:0001325) | 3.35000095 |
| 42 | Hyperglycinuria (HP:0003108) | 3.25201971 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.23084651 |
| 44 | Conjugated hyperbilirubinemia (HP:0002908) | 3.21203154 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 3.19556979 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.19556979 |
| 47 | Meningitis (HP:0001287) | 3.17981612 |
| 48 | Spontaneous hematomas (HP:0007420) | 3.17264737 |
| 49 | Recurrent fungal infections (HP:0002841) | 3.17236995 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.16421691 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 3.13575535 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.09409559 |
| 53 | Gingivitis (HP:0000230) | 3.06904291 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.02749557 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02668378 |
| 56 | Obstructive lung disease (HP:0006536) | 3.02668378 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.97346491 |
| 58 | Increased IgE level (HP:0003212) | 2.93218531 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 2.92588548 |
| 60 | Cellulitis (HP:0100658) | 2.90206966 |
| 61 | Acanthocytosis (HP:0001927) | 2.89537950 |
| 62 | Pustule (HP:0200039) | 2.89095456 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.88837104 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.88792931 |
| 65 | Glomerulonephritis (HP:0000099) | 2.84814502 |
| 66 | Vasculitis (HP:0002633) | 2.82636410 |
| 67 | Mitral stenosis (HP:0001718) | 2.81542875 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.78318533 |
| 69 | Steatorrhea (HP:0002570) | 2.77034326 |
| 70 | Gingival bleeding (HP:0000225) | 2.74070273 |
| 71 | Recurrent skin infections (HP:0001581) | 2.73400119 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 2.65159551 |
| 73 | Spontaneous abortion (HP:0005268) | 2.62926077 |
| 74 | Poikilocytosis (HP:0004447) | 2.62386437 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.61805731 |
| 76 | Skin nodule (HP:0200036) | 2.60751678 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.59408299 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.57258275 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.56683472 |
| 80 | Hypochromic anemia (HP:0001931) | 2.53986075 |
| 81 | Ketoacidosis (HP:0001993) | 2.53727534 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.51581026 |
| 83 | Encephalitis (HP:0002383) | 2.48431902 |
| 84 | Vascular calcification (HP:0004934) | 2.46030935 |
| 85 | Menorrhagia (HP:0000132) | 2.45816351 |
| 86 | Esophageal varix (HP:0002040) | 2.45387098 |
| 87 | Hemoptysis (HP:0002105) | 2.44864817 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 2.42682623 |
| 89 | Cholelithiasis (HP:0001081) | 2.41369317 |
| 90 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.41107633 |
| 91 | Mucopolysacchariduria (HP:0008155) | 2.41107633 |
| 92 | Purpura (HP:0000979) | 2.40437518 |
| 93 | T lymphocytopenia (HP:0005403) | 2.39835049 |
| 94 | Metabolic acidosis (HP:0001942) | 2.39398371 |
| 95 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.39113542 |
| 96 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.39113542 |
| 97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.39113542 |
| 98 | Abnormal gallbladder morphology (HP:0012437) | 2.39052052 |
| 99 | Chest pain (HP:0100749) | 2.37271630 |
| 100 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36700785 |
| 101 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36700785 |
| 102 | Amyloidosis (HP:0011034) | 2.36568640 |
| 103 | Inflammation of the large intestine (HP:0002037) | 2.36440076 |
| 104 | Spastic diplegia (HP:0001264) | 2.31311908 |
| 105 | Colitis (HP:0002583) | 2.31190121 |
| 106 | Recurrent viral infections (HP:0004429) | 2.30627660 |
| 107 | Abnormality of serum amino acid levels (HP:0003112) | 2.30362942 |
| 108 | Thrombophlebitis (HP:0004418) | 2.29291808 |
| 109 | Hemorrhage of the eye (HP:0011885) | 2.28614961 |
| 110 | Urticaria (HP:0001025) | 2.27590124 |
| 111 | Panhypogammaglobulinemia (HP:0003139) | 2.23615440 |
| 112 | Obstructive sleep apnea (HP:0002870) | 2.22784190 |
| 113 | Abnormality of T cell number (HP:0011839) | 2.22717150 |
| 114 | Cardiovascular calcification (HP:0011915) | 2.22452552 |
| 115 | Abnormality of the fingertips (HP:0001211) | 2.21511244 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 2.21419682 |
| 117 | Arterial thrombosis (HP:0004420) | 2.20861657 |
| 118 | Malnutrition (HP:0004395) | 2.20810487 |
| 119 | Anorexia (HP:0002039) | 2.19334513 |
| 120 | Gout (HP:0001997) | 2.18601612 |
| 121 | Polygenic inheritance (HP:0010982) | 2.16802629 |
| 122 | Autoimmune thrombocytopenia (HP:0001973) | 2.15003797 |
| 123 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.14918944 |
| 124 | Nephritis (HP:0000123) | 2.14845777 |
| 125 | Cholecystitis (HP:0001082) | 2.13336701 |
| 126 | Abnormal gallbladder physiology (HP:0012438) | 2.13336701 |
| 127 | Hypoglycemic seizures (HP:0002173) | 2.11124210 |
| 128 | Dicarboxylic aciduria (HP:0003215) | 2.11023521 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11023521 |
| 130 | Increased IgM level (HP:0003496) | 2.10851992 |
| 131 | Sensorimotor neuropathy (HP:0007141) | 2.10479806 |
| 132 | Reticulocytosis (HP:0001923) | 2.09511787 |
| 133 | Emphysema (HP:0002097) | 2.09423159 |
| 134 | Pancreatitis (HP:0001733) | 2.09146510 |
| 135 | Late onset (HP:0003584) | 2.07873588 |
| 136 | Polycythemia (HP:0001901) | 2.07835727 |
| 137 | Interstitial pulmonary disease (HP:0006530) | 2.07136409 |
| 138 | Pulmonary embolism (HP:0002204) | 2.06192088 |
| 139 | Hydroxyprolinuria (HP:0003080) | 2.05770805 |
| 140 | Abnormality of proline metabolism (HP:0010907) | 2.05770805 |
| 141 | Irritability (HP:0000737) | 2.03714766 |
| 142 | Increased mean platelet volume (HP:0011877) | 2.00782291 |
| 143 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.98526974 |
| 144 | Epistaxis (HP:0000421) | 1.96852072 |
| 145 | Increased cerebral lipofuscin (HP:0011813) | 1.96451025 |
| 146 | Abnormal platelet volume (HP:0011876) | 1.95959716 |
| 147 | Neonatal onset (HP:0003623) | 1.95800138 |
| 148 | Abnormality of T cells (HP:0002843) | 1.95378068 |
| 149 | Granulocytopenia (HP:0001913) | 1.95130331 |
| 150 | Loss of speech (HP:0002371) | 1.93778832 |
| 151 | Leukocytosis (HP:0001974) | 1.93607094 |
| 152 | Osteomyelitis (HP:0002754) | 1.92085473 |
| 153 | Lethargy (HP:0001254) | 1.91604729 |
| 154 | Episodic fever (HP:0001954) | 1.91548902 |
| 155 | Cerebral aneurysm (HP:0004944) | 1.91318445 |
| 156 | Acne (HP:0001061) | 1.91287821 |
| 157 | Increased serum ferritin (HP:0003281) | 1.91242331 |
| 158 | Abnormality of the gallbladder (HP:0005264) | 1.90247681 |
| 159 | Lymphopenia (HP:0001888) | 1.89526840 |
| 160 | Broad face (HP:0000283) | 1.88744877 |
| 161 | Premature loss of primary teeth (HP:0006323) | 1.88460939 |
| 162 | Papilloma (HP:0012740) | 1.84884003 |
| 163 | Verrucae (HP:0200043) | 1.84884003 |
| 164 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83721726 |
| 165 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83721726 |
| 166 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83721726 |
| 167 | Gastrointestinal stroma tumor (HP:0100723) | 1.82955429 |
| 168 | Abnormality of the pleura (HP:0002103) | 1.82033172 |
| 169 | Impaired platelet aggregation (HP:0003540) | 1.81677561 |
| 170 | Abnormal platelet function (HP:0011869) | 1.81677561 |
| 171 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81222839 |
| 172 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.80843153 |
| 173 | Subacute progressive viral hepatitis (HP:0006572) | 1.80818307 |
| 174 | Hypertriglyceridemia (HP:0002155) | 1.78395725 |
| 175 | Abnormal cartilage morphology (HP:0002763) | 1.78324903 |
| 176 | Generalized aminoaciduria (HP:0002909) | 1.75942475 |
| 177 | Elevated hepatic transaminases (HP:0002910) | 1.74712897 |
| 178 | Stroke (HP:0001297) | 1.73221567 |
| 179 | Peritonitis (HP:0002586) | 1.70737418 |
| 180 | Vomiting (HP:0002013) | 1.70117411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.63393679 |
| 2 | BCKDK | 4.00939402 |
| 3 | FGFR4 | 3.58625970 |
| 4 | PRPF4B | 3.44385613 |
| 5 | SIK1 | 3.41966589 |
| 6 | TAOK3 | 3.08372329 |
| 7 | TRIB3 | 3.05002607 |
| 8 | MAP3K10 | 2.82650974 |
| 9 | TYK2 | 2.71042060 |
| 10 | PKN2 | 2.66694004 |
| 11 | MAP4K1 | 2.32469960 |
| 12 | TBK1 | 2.13524192 |
| 13 | MAP3K14 | 1.99791066 |
| 14 | SMG1 | 1.99334630 |
| 15 | TNK2 | 1.82417175 |
| 16 | GRK6 | 1.82244048 |
| 17 | JAK1 | 1.72174974 |
| 18 | PTK6 | 1.70712711 |
| 19 | FLT3 | 1.69036863 |
| 20 | FES | 1.64561357 |
| 21 | BLK | 1.61922853 |
| 22 | MAP2K3 | 1.61782098 |
| 23 | NEK9 | 1.58536127 |
| 24 | EPHB1 | 1.58088999 |
| 25 | MAPK11 | 1.51736969 |
| 26 | TGFBR2 | 1.46008379 |
| 27 | MST1R | 1.45618291 |
| 28 | IKBKE | 1.38374389 |
| 29 | INSRR | 1.35944989 |
| 30 | JAK2 | 1.35481809 |
| 31 | CSF1R | 1.30616960 |
| 32 | JAK3 | 1.27159599 |
| 33 | IRAK3 | 1.26934993 |
| 34 | CSK | 1.26753913 |
| 35 | PIK3CG | 1.24649288 |
| 36 | FRK | 1.22922516 |
| 37 | PRKD2 | 1.22209842 |
| 38 | KIT | 1.18452115 |
| 39 | SIK3 | 1.16953191 |
| 40 | MARK2 | 1.16863273 |
| 41 | ERBB4 | 1.15867644 |
| 42 | ZAP70 | 1.13209587 |
| 43 | CDC42BPA | 1.08728340 |
| 44 | MAP3K7 | 1.07767981 |
| 45 | CAMK1D | 1.07452192 |
| 46 | FGFR3 | 1.05494358 |
| 47 | IKBKB | 1.04138641 |
| 48 | CDK6 | 1.03920067 |
| 49 | MAP3K13 | 1.03841223 |
| 50 | KDR | 1.02540446 |
| 51 | MAP3K3 | 1.02403942 |
| 52 | RIPK1 | 1.01441512 |
| 53 | STK24 | 1.00920931 |
| 54 | EEF2K | 0.99180258 |
| 55 | PRKAA2 | 0.92754119 |
| 56 | BTK | 0.91620731 |
| 57 | ABL2 | 0.91234926 |
| 58 | NLK | 0.90043063 |
| 59 | LRRK2 | 0.89631017 |
| 60 | HIPK2 | 0.89122235 |
| 61 | MAP3K2 | 0.87249473 |
| 62 | FGR | 0.85169195 |
| 63 | RPS6KC1 | 0.85087877 |
| 64 | RPS6KL1 | 0.85087877 |
| 65 | IRAK2 | 0.84134211 |
| 66 | MARK3 | 0.83850126 |
| 67 | CHUK | 0.83448122 |
| 68 | SYK | 0.83445497 |
| 69 | MAPK4 | 0.83396834 |
| 70 | STK10 | 0.83395255 |
| 71 | DYRK1B | 0.82750128 |
| 72 | EPHA3 | 0.81661599 |
| 73 | KSR2 | 0.81297658 |
| 74 | IRAK1 | 0.79447235 |
| 75 | MAP3K11 | 0.76201765 |
| 76 | CDK4 | 0.76082064 |
| 77 | LATS1 | 0.75848844 |
| 78 | RPS6KA2 | 0.74653253 |
| 79 | PIM1 | 0.73699448 |
| 80 | IRAK4 | 0.73121779 |
| 81 | MAP2K4 | 0.72466679 |
| 82 | RPS6KA6 | 0.71000968 |
| 83 | STK38 | 0.69641318 |
| 84 | STK4 | 0.69331550 |
| 85 | CAMKK1 | 0.68801919 |
| 86 | TTN | 0.67333855 |
| 87 | BMX | 0.66998336 |
| 88 | EPHA2 | 0.66905142 |
| 89 | MAP3K6 | 0.64421568 |
| 90 | SGK3 | 0.63882932 |
| 91 | MAPK12 | 0.60782968 |
| 92 | HCK | 0.60527932 |
| 93 | ITK | 0.56832578 |
| 94 | PDPK1 | 0.56005368 |
| 95 | LYN | 0.55495270 |
| 96 | PAK4 | 0.55053669 |
| 97 | PRKCQ | 0.54188926 |
| 98 | SIK2 | 0.53801468 |
| 99 | CAMK1G | 0.52498271 |
| 100 | GSK3A | 0.52141839 |
| 101 | MELK | 0.50210672 |
| 102 | PRKG2 | 0.50202043 |
| 103 | STK3 | 0.50013959 |
| 104 | PDK1 | 0.49923805 |
| 105 | FGFR2 | 0.49490174 |
| 106 | RET | 0.47653546 |
| 107 | PRKCZ | 0.47561841 |
| 108 | DAPK2 | 0.46414318 |
| 109 | YES1 | 0.45530364 |
| 110 | TESK2 | 0.45490831 |
| 111 | MAP3K5 | 0.44384612 |
| 112 | LCK | 0.44096451 |
| 113 | TAOK2 | 0.43913299 |
| 114 | PRKAA1 | 0.43204145 |
| 115 | FYN | 0.42981891 |
| 116 | EGFR | 0.42625329 |
| 117 | PRKACG | 0.41243246 |
| 118 | PTK2 | 0.40574898 |
| 119 | MAPKAPK2 | 0.40379172 |
| 120 | MATK | 0.39179485 |
| 121 | ABL1 | 0.37936155 |
| 122 | MTOR | 0.37564836 |
| 123 | PDGFRB | 0.37276710 |
| 124 | MAPK7 | 0.36956657 |
| 125 | MAP2K6 | 0.36436140 |
| 126 | MAP3K8 | 0.35696043 |
| 127 | RIPK4 | 0.35643426 |
| 128 | TAOK1 | 0.35325559 |
| 129 | ERBB2 | 0.35188093 |
| 130 | CDK12 | 0.33840151 |
| 131 | MAP3K1 | 0.32490611 |
| 132 | RPS6KA4 | 0.29207636 |
| 133 | TXK | 0.29041691 |
| 134 | ICK | 0.27725931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.40062325 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59810485 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.52417216 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40954750 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97609198 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.86701130 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67995424 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52077288 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46646644 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42092805 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39576139 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31360318 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.24045117 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22960596 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.04476125 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.03612023 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.01823671 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.97805591 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93811015 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87948763 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87017537 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86129831 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82752886 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80267545 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80237666 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75501484 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.73623923 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72521318 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70330700 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70147342 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68595622 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66718335 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.66615789 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.63547171 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62568331 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.62405173 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.60217681 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53494315 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52780042 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52223480 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.52131774 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49661904 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46125782 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44602562 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44458698 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43251569 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.39306696 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34393569 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31290383 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29379772 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29118928 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29105067 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28066030 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27915845 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27408924 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27347349 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24105098 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23539834 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23277826 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23261530 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20659634 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 1.17565796 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17207411 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16767503 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16440507 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.15027567 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14288830 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13969010 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10623772 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10263625 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09899373 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08379825 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06268933 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03217343 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02574486 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99889942 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99373585 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97586696 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96193242 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95395787 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94257981 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.94026795 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93412438 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.93279753 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93160355 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.93082462 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93077974 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90670917 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.89987643 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88124103 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.87845138 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.85405414 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83131370 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82655963 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79182430 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78738730 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.77473511 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76144625 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74718207 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.73514206 |
| 101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73173109 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.72484770 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72472086 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71662267 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70856612 |
| 106 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70471738 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69613582 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65935906 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65176896 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64254976 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.63074201 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62010826 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61686363 |
| 114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61457826 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60450044 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60057547 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59991905 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59852417 |
| 119 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58290017 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58039615 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57398960 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56944504 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56528905 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54234078 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54196170 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53931714 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53289602 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.52881666 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52535687 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51074377 |
| 131 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49499035 |
| 132 | Asthma_Homo sapiens_hsa05310 | 0.49482507 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49201431 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.48541542 |
| 135 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47946066 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46945687 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.45762196 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42902595 |
| 139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35564345 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.30977795 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29738850 |
| 142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25395582 |
| 143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24511204 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19984691 |
| 145 | Leishmaniasis_Homo sapiens_hsa05140 | 0.17996138 |
| 146 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.17495057 |
| 147 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15218044 |
| 148 | Pertussis_Homo sapiens_hsa05133 | 0.14092351 |
| 149 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.14008344 |
| 150 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.13330943 |
| 151 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.13223806 |
| 152 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.11223716 |
| 153 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.10917946 |
| 154 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.10887470 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.10335108 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08055007 |
| 157 | Hepatitis C_Homo sapiens_hsa05160 | 0.07582279 |
| 158 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06343676 |
| 159 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06035031 |
| 160 | Lysosome_Homo sapiens_hsa04142 | 0.05602545 |
| 161 | Malaria_Homo sapiens_hsa05144 | 0.02413132 |
| 162 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.02006111 |
| 163 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00991475 |
| 164 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0311680 |
| 165 | Influenza A_Homo sapiens_hsa05164 | -0.0249404 |
| 166 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0219431 |
| 167 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0216912 |
| 168 | Measles_Homo sapiens_hsa05162 | -0.0200633 |
| 169 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0150512 |
| 170 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.0104555 |
| 171 | Legionellosis_Homo sapiens_hsa05134 | -0.0018298 |

